Evidence map›Paper›PMID 29848975›Full record

ArticleInternational journal of molecular sciences2018

Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson's Disease: An In Situ Proximity Ligation Assay Study.

Francesca Longhena, Gaia Faustini, Cristina Missale, Marina Pizzi, Arianna Bellucci

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Seeing Invisible Oligomers: Rethinking α-Synuclein Pathology Through Proximity Ligation Assay.Movement disorders : official journal of the Movement Disorder Society · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Advancement in human neuroimaging based on proximity ligation assay in brain disease.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  12. Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  13. Article
  14. The Association between α-Synuclein and α-Tubulin in Brain Synapses.International journal of molecular sciences · 2021
    Article
  15. Review
  16. Review
  17. Frontiers in neuroscience · 2020
    Article
  18. Article
  19. Revealing Adenosine AInternational journal of molecular sciences · 2019
    Article
  20. Is Braak staging valid for all types of Parkinson's disease?Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francesca LonghenaDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. f.longhena@unibs.it.ORCID 0000-0001-6569-9412
Gaia FaustiniDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. g.faustini004@unibs.it.ORCID 0000-0002-0751-3082
Cristina MissaleDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. mariacristina.missale@unibs.it.
Marina PizziDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. marina.pizzi@unibs.it.
Arianna BellucciDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. arianna.bellucci@unibs.it.ORCID 0000-0002-9581-1919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-protein interactions in tissues to detect dopamine transporter (DAT)/α-synuclein complexes, we previously described that these are markedly redistributed in the striatum of human α-synuclein transgenic mice at the phenotypic stage, showing dopamine (DA) release impairment without a DAT drop and motor symptoms. Here, we used the in situ PLA to investigate DAT/α-synuclein complexes in the caudate putamen of PD patients and age-matched controls. They were found to be redistributed and showed an increased size in PD patients, where we observed several neuropil-like and neuritic-like PLA-positive structures. In the PD brains, DAT immunolabeling showed a pattern similar to that of in situ PLA in areas with abundant α-synuclein neuropathology. This notwithstanding, the in situ PLA signal was only partially retracing DAT or α-synuclein immunolabeling, suggesting that a large amount of complexes may have been lost along with the degeneration process. These findings reveal a DAT/α-synuclein neuropathological signature in PD and hint that synaptic alterations involving striatal DAT may derive from α-synuclein aggregation.

Indexed as

AgedAged, 80 and overalpha-SynucleinAnimalsDopamine Plasma Membrane Transport ProteinsFemaleHumansImmunohistochemistryIn Vitro TechniquesMaleMice, TransgenicParkinson Diseasealpha-SynucleinDopamine Plasma Membrane Transport Proteinsdopamine transporterParkinson’s diseaseproximity ligation assayα-synuclein

Identifiers

PMID29848975
PMCPMC6032099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.